A phase II study of raltitrexed ('Tomudex') in patients with hepatocellular carcinoma

Annals of Oncology

Volumn 8, Issue 5, 1997, Pages 500-502

  Rougier, P ^a   Ducreux, M ^a   Kerr, D ^b   Carr, B I ^c   Francois E ^d   Adenis, A ^e   Seymour, L ^f  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c Division of Transplantation   (United States)

^d CENTRE ANTOINE LACASSAGNE   (France)

^e CENTRE OSCAR LAMBRET   (France)

^f ASTRAZENECA   (United Kingdom)

Author keywords

Chemotherapy; Hepatocellular carcinoma; Raltitrexed; Tomudex; Treatment outcome

Indexed keywords

ALPHA FETOPROTEIN; RALTITREXED;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASTHENIA; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER CELL CARCINOMA; MALE; MULTICENTER STUDY; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLIC ACID ANTAGONISTS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; QUINAZOLINES; THIOPHENES;

EID: 0030805676     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008249328792     Document Type: Article

References (9)

1. Lotze MT, Flickinger JC, Carr BI. Hepatobiliary neoplasms. In De Vita VT Jr, Hellman S, Rosenberg SA (eds): Cancer, Principles and Practice of Oncology, 4th edition. Philadelphia: Lippincott 1993.
2. Lai C-L, Wu P-C, Chan GCB et al. Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trial. Cancer 1988; 62: 479-83.
3. Bassendine MF, Curtin NJ, Loose H et al. Induction of remission in hepatocellular carcinoma with a new thymidylate synthase inhibitor, CB3717. A phase II study. J Hepatol 1987; 4: 349-56.
4. Jackman AL, Farrugia DC, Gibson W et al. ZD 1694 (Tomudex): A new thymidylate synthase inhibitor with activity in colorectal cancer. Eur J Cancer 1995; 31A: 1277-82.
5. Di Bisceglie AM, Rustgi VK, Hoofnagle JH et al. Hepatocellular carcinoma. Ann Intern Med 1988; 108: 390-401.
6. Muir C, Cancer Incidence in Five Continents. IARC Scientific Publications, Vol. V, No. 88. Lyon: International Agency for Research in Cancer 1987.
7. Nagao T, Inoue S, Yoshimi F et al. Post-operative recurrence of hepatocellular carcinoma. Ann Surg 1990; 211: 28-33.
8. Calvet X, Bruix J, Bru C et al. Natural history of hepatocellular carcinoma in Spain. Five year's experience in 249 cases. J Hepatol 1990; 10: 311-7.
9. Nerenstone SR, Ihde DC, Friedman MA, Clinical trials in primary hepatocellular carcinoma: Current status and future directions. Cancer Treat Rev 1988: 15: 1-31.